Andon Health to cut capital, expand business, elect new board

Tianjin Andon Health Co., Ltd. held its 6th Board of Directors' 29th meeting on November 28, 2025, approving several key changes. The company's registered capital will decrease from 486,140,322 yuan to 464,919,840 yuan due to stock option exercises and share cancellations. The business scope will expand to include "sales of health foods (pre-packaged)" and "sales of plastic products," pending market supervision approval.

Concurrently, the board approved amendments to the Articles of Association and various internal policies, reflecting changes in corporate governance, including the removal of the supervisory board and supervisors, with the audit committee assuming the responsibilities previously held by the supervisory board.

Furthermore, the board approved the re-election of directors for the 7th Board, consisting of six members: three non-independent directors (including one employee director) and three independent directors. The proposed non-independent directors are Liu Yi and Wang Yong, while the independent director candidates are Bi Xiaofang, Sun Weijun, and He Shuguang. These nominations, along with the amendments to the Articles of Association and selected internal policies, will be submitted for approval at the 2025 Fourth Interim Shareholders' Meeting on December 15, 2025. The board also approved the re-appointment of Rongcheng Certified Public Accountants as the company's 2025 audit firm.